Medicine and Dentistry
Pediatrics
100%
Ganglioglioma
63%
Neoplasm
62%
Central Nervous System
52%
Germinoma
51%
Medulloblastoma
40%
Radiation Therapy
33%
Central Nervous System Tumor
27%
Surgery
27%
Craniospinal Irradiation
24%
Diseases
22%
Clinical Trial
20%
Intracranial Tumor
20%
Hematopoietic Cell
19%
Non Seminomatous Germinoma
19%
Overall Survival
18%
Neuro-Oncology
16%
Atypical Teratoid Rhabdoid Tumor
16%
Everolimus
15%
Toddlers
13%
Diagnosis
13%
Meta-Analysis
13%
Germ Cell
13%
Pediatric Brain Tumor
13%
Chemotherapy
12%
Induction Chemotherapy
12%
Pilocytic Astrocytoma
11%
Solid Malignant Neoplasm
10%
Malignant Neoplasm
10%
Medicine
10%
Cerebrospinal Fluid
9%
Dentigerous Cyst
9%
Childhood Cancer
9%
Adolescence
9%
Disease Predisposition
8%
Ventricle of Heart
8%
Progression Free Survival
8%
Prognostic Factor
8%
Magnetic Resonance Imaging
8%
Recurrent Disease
8%
Basal Ganglia
7%
Malignant Rhabdoid Tumour
7%
Event Free Survival
7%
Adverse Event
7%
Intrathecal Drug Administration
7%
G 207
6%
Rosette Formation
6%
Rhabdoid Tumor
6%
Neoadjuvant Chemotherapy
6%
Pleomorphic Xanthoastrocytoma
6%
Keyphrases
Pediatric
41%
Tumor
38%
Central Nervous System
37%
Medulloblastoma
33%
Chemotherapy
31%
Central Nervous System Tumors
29%
Pediatric Low-grade Glioma
26%
Craniospinal Irradiation
24%
Older Adults
23%
Non-seminomatous Germ Cell Tumor (NSGCT)
23%
Low-grade Glioma
20%
Pediatric Brain Tumor
20%
Radiotherapy
20%
Atypical Teratoid Rhabdoid Tumor (AT/RT)
17%
Relapsed or Refractory
17%
Pediatric Glioma
17%
Solid Tumors
17%
Pediatric Neuro-oncology
17%
Treatment Modalities
17%
Clinical Trials
16%
Survivors
16%
Everolimus
16%
Ablative
15%
Marrow
15%
Treatment Strategy
15%
Irradiation
15%
Tumors in children
14%
Central Nervous System Germ Cell Tumor
14%
Overall Survival
14%
Meta-analysis
13%
BRAF Inhibitor (BRAFi)
13%
Multi-institutional Analysis
13%
Young children
13%
Firefly
13%
Germinoma
13%
Rhabdoid Tumor
13%
Chemotherapy Regimen
12%
Germ Cell Tumor
12%
Induction Chemotherapy
12%
Radiation Therapy
12%
Hematopoietic Cells
11%
Pediatric Population
11%
Confidence Interval
11%
Surgical Resection
10%
Central Nervous System Germinoma
10%
ROS1 Fusion
10%
Brain Tumor
10%
Pediatric Patients
10%
Pilocytic Astrocytoma
10%
High-grade Glioma
9%